MarketLens
Sign Up

Sabre's "Poison Pill" — A Defensive Maneuver

6 months ago
SHARE THIS ON:

Sabre's "Poison Pill" — A Defensive Maneuver

Exclusive Content for Pro Members

Pro members only. Upgrade to access this article, premium analysis, and stock recommendations.

SHARE THIS ON:

Related Articles

Category

You may also like

News4 days ago

Tokyo court blocks Toho poison pill in test of anti-activist defences

A Tokyo court on Friday blocked Toho Holdings' poison pill against an activist shareholder, in a closely watched case as Japanese companies increasingly adopt takeover defenses.
Stock News1 week ago

Sabre Corporation Announces Additional Cash Tender Offers by Sabre GLBL Inc. for Existing Secured Debt

Sabre GLBL launched additional cash tender offers for secured debt, capped at a $250M aggregate purchase price, to repurchase existing notes. The move aims to manage the subsidiary's debt profile.
Stock News2 months ago

Diana Shipping Inc. Asks: Why is Genco So Afraid of Diana's Tender Offer?

Diana Shipping (DSX) escalated pressure on Genco (GNK) with a $27.34/share offer ($24.80 cash plus one Diana share), accusing Genco's board of stalling via a poison pill and petty technicalities.

Breaking News

View All →

Top Headlines

View More →
Stock News1 hour ago

BABA 13-DAY DEADLINE ALERT: Alibaba Group Holding Limited Investors with Substantial Losses Have Opportunity to Lead Shareholder Class Action Lawsuit Before October 5, 2026 Lead Plaintiff Deadline

Stock News2 hours ago

Nasdaq Scores Record As Oil Eases; Apple Tests Buy Point

Stock News2 hours ago

INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Alibaba Group Holding Limited of Class Action Lawsuit and Upcoming Deadlines – BABA

Stock News2 hours ago

Meta Was the Worst AI Lab

Stock News3 hours ago

Why Apple could soon join Nvidia in the exclusive $5 trillion club